Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invus Public Equities Advisors is the specialized investment arm of The Invus Group, focusing on public and late-stage private companies within the life sciences and healthcare sectors. The firm operates with an evergreen capital structure, primarily backed by the Artal Group, which allows for a significantly longer investment horizon than traditional venture capital or hedge funds. They are known for taking concentrated, high-conviction positions in biotechnology companies that possess transformative technology platforms or novel therapeutic candidates. Invus Public Equities Advisors provides strategic support to its portfolio companies, leveraging deep sector expertise to navigate clinical development and regulatory pathways. Their investment strategy emphasizes fundamental research and a partnership-oriented approach to value creation in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invus Public Equities Advisors.